Known history or confirmation of active pneumonia, pneumonitis, symptomatic interstitial lung disease, or definitive evidence of interstitial lung disease described on CT scan, MRI, or chest x-ray in asymptomatic patients; dyspnea at rest requiring current continuous oxygen therapy.
Patients with evidence of interstitial lung disease (bilateral, diffuse, parenchymal lung disease)
Evidence of interstitial lung disease
History or any evidence of interstitial lung disease;
Participants must not have evidence of interstitial lung disease
Presence of cavitation of central pulmonary lesion, or radiographic evidence of pneumonitis or other extensive bilateral lung disease such as interstitial lung disease
Evidence of interstitial lung disease
Has evidence of interstitial lung disease
Has evidence of interstitial lung disease
Evidence of interstitial lung disease
Has evidence of interstitial lung disease
Evidence of interstitial lung disease
History of, or evidence of clinically active, interstitial lung disease
Has evidence or a history of interstitial lung disease
Has evidence of interstitial lung disease
Has evidence of interstitial lung disease
Has evidence of interstitial lung disease
Has evidence of interstitial lung disease
Patient has evidence of interstitial lung disease
Evidence of interstitial lung disease
Evidence of interstitial lung disease
Known history of active pneumonia, pneumonitis, symptomatic interstitial lung disease, or definitive evidence of interstitial lung disease described on CT scan, MRI, or chest x-ray in asymptomatic patients; dyspnea at rest requiring current continuous oxygen therapy.
Evidence of interstitial lung disease
Evidence of interstitial lung disease
Evidence of interstitial lung disease
Symptomatic interstitial lung disease or definitive evidence of interstitial lung disease described on CT scan, MRI, or chest x-ray in asymptomatic patients; dyspnea at rest requiring current continuous oxygen.
Any evidence of clinically active interstitial lung disease (patients with chronic stable radiographic changes who are asymptomatic need not be excluded)
Evidence of interstitial lung disease
Has evidence of interstitial lung disease
Other clinically severe or uncontrolled systemic illness or any concurrent condition that in the view of the principal investigator could compromise the participantâ€™s ability to tolerate vandetanib or could compromise study procedures or endpoints, including interstitial lung disease, drug-induced interstitial disease, radiation pneumonitis which required steroid treatment or any evidence of clinically active interstitial lung disease
Any evidence of clinically active interstitial lung disease
Symptomatic interstitial lung disease or definitive evidence of interstitial lung disease described on CT scan, MRI, or chest x-ray in asymptomatic patients; dyspnea at rest requiring current continuous oxygen therapy.
Patients with evidence of interstitial lung disease
Known history of, or any evidence of, interstitial lung disease
Any evidence of clinically significant interstitial lung disease
Subject has history of drug-induced interstitial lung disease or any evidence of active interstitial lung disease.
Evidence of interstitial lung disease.
Any evidence of clinically active interstitial lung disease (patients with chronic,stable, radiographic changes who are asymptomatic need not be excluded).
